Point of Care Testing Market Size By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy & Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-Abuse Testing, Fecal Occult Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 – 2030

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast parameters

1.4    Data validation

1.5    Data Sources

1.5.1    Secondary

1.5.1.1   Paid sources

1.5.1.2   Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Point of care testing industry 360^° synopsis, 2017 - 2030

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Technology trends

2.1.4    Prescription trends

2.1.5    Application trends

2.1.6    End-use trends

2.1.7    Regional trends

Chapter 3   Point of Care Testing Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Upward trend in disease prevalence among developing countries

3.3.1.2   Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America

3.3.1.3   Technological advancements

3.3.1.4   Increasing R&D investment

3.3.1.5   Growing geriatric population base globally

3.3.2    Industry pitfalls & challenges

3.3.2.1   Increasing R&D investment

3.3.2.2   High cost of product development

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By technology

3.4.3    By prescription

3.4.4    By application

3.4.5    By end-use

3.5    COVID-19 impact analysis

3.6    Pricing analysis, by cardiac markers, 2021

3.7    Regulatory landscape

3.8    Technology landscape

3.9    Company share analysis, 2021 (by region)

3.9.1    Global market share analysis, 2021

3.9.2    North America

3.9.3    Europe

3.9.4    Asia Pacific

3.9.5    Latin America

3.9.6    MEA

3.10    Porter’s analysis

3.11    Competitive landscape, 2021

3.11.1    Company matrix analysis, 2021

3.12    PESTEL analysis

Chapter 4   Point of Care Testing Market, By Product

4.1    Key segment trends

4.2    Glucose monitoring

4.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2    Strips

4.2.2.1   Market size, by region, 2017 - 2030 (USD Million)

4.2.3    Meters

4.2.3.1   Market size, by region, 2017 - 2030 (USD Million)

4.2.4    Lancets

4.2.4.1   Market size, by region, 2017 - 2030 (USD Million)

4.3    Cardiometabolic testing products

4.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.3.2    Cardiac marker testing products

4.3.2.1   Market size, by region, 2017-2030 (USD Million)

4.3.2.2   High sensitivity troponin I (hsTnI)

4.3.2.2.1    Market size, by region, 2017-2030 (USD Million)

4.3.2.3   Brain natriuretic peptide (BNP)

4.3.2.3.1    Market size, by region, 2017-2030 (USD Million)

4.3.2.4   D-dimer

4.3.2.4.1    Market size, by region, 2017-2030 (USD Million)

4.3.2.5   Creatine kinase-MB (CK-MB)

4.3.2.5.1    Market size, by region, 2017-2030 (USD Million)

4.3.2.6   Myoglobin

4.3.2.6.1    Market size, by region, 2017-2030 (USD Million)

4.3.2.7   Others

4.3.2.7.1    Market size, by region, 2017-2030 (USD Million)

4.3.3    Blood Gas/Electrolytes testing products

4.3.3.1   Market size, by region, 2017-2030 (USD Million)

4.3.4    HBA1C testing products

4.3.4.1   Market size, by region, 2017-2030 (USD Million)

4.4    Infectious disease testing products

4.4.1    Market size, by region, 2017-2030 (USD Million)

4.4.2    Influenza testing products

4.4.2.1   Market size, by region, 2017-2030 (USD Million)

4.4.3    HIV testing products

4.4.3.1   Market size, by region, 2017-2030 (USD Million)

4.4.4    Hepatitis C testing products

4.4.4.1   Market size, by region, 2017-2030 (USD Million)

4.4.5    Sexually transmitted disease (STD) testing products

4.4.5.1   Market size, by region, 2017-2030 (USD Million)

4.4.6    Healthcare-associated Infection (HAI) testing products

4.4.6.1   Market size, by region, 2017-2030 (USD Million)

4.4.7    Respiratory infection testing products

4.4.7.1   Market size, by region, 2017-2030 (USD Million)

4.4.8    Tropical disease testing products

4.4.8.1   Market size, by region, 2017-2030 (USD Million)

4.4.9    Other infectious diseases testing products

4.4.9.1   Market size, by region, 2017-2030 (USD Million)

4.5    Coagulation testing products

4.5.1    Market size, by region, 2017-2030 (USD Million)

4.5.2    PT/INR testing products

4.5.2.1   Market size, by region, 2017-2030 (USD Million)

4.5.3    Activated clotting time (ACT/APTT) testing products

4.5.3.1   Market size, by region, 2017-2030 (USD Million)

4.6    Pregnancy & fertility testing products

4.6.1    Market size, by region, 2017-2030 (USD Million)

4.6.2    Pregnancy testing products

4.6.2.1   Market size, by region, 2017-2030 (USD Million)

4.6.3    Fertility testing products

4.6.3.1   Market size, by region, 2017-2030 (USD Million)

4.7    Tumor/Cancer marker testing products

4.7.1    Market size, by region, 2017-2030 (USD Million)

4.8    Cholesterol testing products

4.8.1    Market size, by region, 2017-2030 (USD Million)

4.9    Hematology testing products

4.9.1    Market size, by region, 2017-2030 (USD Million)

4.10    Drug-of-Abuse (DoA) testing products

4.10.1    Market size, by region, 2017-2030 (USD Million)

4.11    Fecal occult testing products

4.11.1    Market size, by region, 2017-2030 (USD Million)

4.12    Urinalysis testing products

4.12.1    Market size, by region, 2017-2030 (USD Million)

4.13    Other products

4.13.1    Market size, by region, 2017-2030 (USD Million)

Chapter 5   Point of Care Testing Market, By Technology

5.1    Key segment trends

5.2    Lateral flow assays

5.2.1    Market size, by region, 2017 - 2030 (USD Million)

5.3    Dipsticks

5.3.1    Market size, by region, 2017 - 2030 (USD Million)

5.4    Microfluidics

5.4.1    Market size, by region, 2017 - 2030 (USD Million)

5.5    Molecular diagnostics

5.5.1    Market size, by region, 2017 - 2030 (USD Million)

5.6    Immunoassays

5.6.1    Market size, by region, 2017 - 2030 (USD Million)

5.7    Agglutination assays

5.7.1    Market size, by region, 2017 - 2030 (USD Million)

5.8    Flow-through

5.8.1    Market size, by region, 2017 - 2030 (USD Million)

5.9    Solid phase

5.9.1    Market size, by region, 2017 - 2030 (USD Million)

5.10    Biosensors

5.10.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 6   Point of Care Testing Market, By Prescription

6.1    Key segment trends

6.2    OTC testing

6.2.1    Market size, by region, 2017 - 2030 (USD Million)

6.3    Prescription-based testing

6.3.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 7   Point of Care Testing Market, By Application

7.1    Key segment trends

7.2    Cardio metabolic testing

7.2.1    Market size, by region, 2017 - 2030 (USD Million)

7.3    Infectious disease testing

7.3.1    Market size, by region, 2017 - 2030 (USD Million)

7.4    Nephrology testing

7.4.1    Market size, by region, 2017 - 2030 (USD Million)

7.5    Drug-of-Abuse (DoA) testing

7.5.1    Market size, by region, 2017 - 2030 (USD Million)

7.6    Blood glucose testing

7.6.1    Market size, by region, 2017 - 2030 (USD Million)

7.7    Pregnancy testing

7.7.1    Market size, by region, 2017 - 2030 (USD Million)

7.8    Cancer biomarker testing

7.8.1    Market size, by region, 2017 - 2030 (USD Million)

7.9    Other applications

7.9.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 8   Point of Care Testing Market, By End-use

8.1    Key segment trends

8.2    Hospitals

8.2.1    Market size, by region, 2017 - 2030 (USD Million)

8.3    Diagnostic centers

8.3.1    Market size, by region, 2017 - 2030 (USD Million)

8.4    Research laboratories

8.4.1    Market size, by region, 2017 - 2030 (USD Million)

8.5    Home-care settings

8.5.1    Market size, by region, 2017 - 2030 (USD Million)

8.6    other

8.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 9   Point of Care Testing Market, By Region

9.1    Key regional trends

9.2    North America

9.2.1    Market size, by country, 2017 - 2030 (USD Million)

9.2.2    Market size, by product, 2017 - 2030 (USD Million)

9.2.2.1   Market size, by glucose monitoring, 2017-2030 (USD Million)

9.2.2.2   Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.2.2.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.2.2.3   Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.2.2.4   Market size, by coagulation testing products, 2017-2030 (USD Million)

9.2.2.5   Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.2.3    Market size, by technology, 2017 - 2030 (USD Million)

9.2.4    Market size, by prescription, 2017 - 2030 (USD Million)

9.2.5    Market size, by application, 2017 - 2030 (USD Million)

9.2.6    Market size, by end-use, 2017 - 2030 (USD Million)

9.2.7    U.S.

9.2.7.1   Market size, by product, 2017 - 2030 (USD Million)

9.2.7.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.2.7.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.2.7.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.2.7.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.2.7.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.2.7.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.2.7.2   Market size, by technology, 2017 - 2030 (USD Million)

9.2.7.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.2.7.4   Market size, by application, 2017 - 2030 (USD Million)

9.2.7.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.2.8    Canada

9.2.8.1   Market size, by product, 2017 - 2030 (USD Million)

9.2.8.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.2.8.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.2.8.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.2.8.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.2.8.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.2.8.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.2.8.2   Market size, by technology, 2017 - 2030 (USD Million)

9.2.8.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.2.8.4   Market size, by application, 2017 - 2030 (USD Million)

9.2.8.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.3    Europe

9.3.1    Market size, by country, 2017 - 2030 (USD Million)

9.3.2    Market size, by product, 2017 - 2030 (USD Million)

9.3.2.1   Market size, by glucose monitoring, 2017-2030 (USD Million)

9.3.2.2   Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.3.2.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.3.2.3   Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.3.2.4   Market size, by coagulation testing products, 2017-2030 (USD Million)

9.3.2.5   Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.3.3    Market size, by technology, 2017 - 2030 (USD Million)

9.3.4    Market size, by prescription, 2017 - 2030 (USD Million)

9.3.5    Market size, by application, 2017 - 2030 (USD Million)

9.3.6    Market size, by end-use, 2017 - 2030 (USD Million)

9.3.7    Germany

9.3.7.1   Market size, by product, 2017 - 2030 (USD Million)

9.3.7.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.3.7.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.3.7.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.3.7.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.3.7.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.3.7.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.3.7.2   Market size, by technology, 2017 - 2030 (USD Million)

9.3.7.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.3.7.4   Market size, by application, 2017 - 2030 (USD Million)

9.3.7.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.3.8    UK

9.3.8.1   Market size, by product, 2017 - 2030 (USD Million)

9.3.8.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.3.8.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.3.8.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.3.8.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.3.8.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.3.8.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.3.8.2   Market size, by technology, 2017 - 2030 (USD Million)

9.3.8.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.3.8.4   Market size, by application, 2017 - 2030 (USD Million)

9.3.8.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.3.9    France

9.3.9.1   Market size, by product, 2017 - 2030 (USD Million)

9.3.9.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.3.9.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.3.9.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.3.9.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.3.9.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.3.9.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.3.9.2   Market size, by technology, 2017 - 2030 (USD Million)

9.3.9.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.3.9.4   Market size, by application, 2017 - 2030 (USD Million)

9.3.9.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.3.10    Spain

9.3.10.1    Market size, by product, 2017 - 2030 (USD Million)

9.3.10.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.3.10.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.3.10.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.3.10.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.3.10.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.3.10.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.3.10.2    Market size, by technology, 2017 - 2030 (USD Million)

9.3.10.3    Market size, by prescription, 2017 - 2030 (USD Million)

9.3.10.4    Market size, by application, 2017 - 2030 (USD Million)

9.3.10.5    Market size, by end-use, 2017 - 2030 (USD Million)

9.3.11    Italy

9.3.11.1    Market size, by product, 2017 - 2030 (USD Million)

9.3.11.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.3.11.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.3.11.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.3.11.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.3.11.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.3.11.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.3.11.2    Market size, by technology, 2017 - 2030 (USD Million)

9.3.11.3    Market size, by prescription, 2017 - 2030 (USD Million)

9.3.11.4    Market size, by application, 2017 - 2030 (USD Million)

9.3.11.5    Market size, by end-use, 2017 - 2030 (USD Million)

9.4    Asia Pacific

9.4.1    Market size, by country, 2017 - 2030 (USD Million)

9.4.2    Market size, by product, 2017 - 2030 (USD Million)

9.4.2.1   Market size, by glucose monitoring, 2017-2030 (USD Million)

9.4.2.2   Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.4.2.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.4.2.3   Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.4.2.4   Market size, by coagulation testing products, 2017-2030 (USD Million)

9.4.2.5   Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.4.3    Market size, by technology, 2017 - 2030 (USD Million)

9.4.4    Market size, by prescription, 2017 - 2030 (USD Million)

9.4.5    Market size, by application, 2017 - 2030 (USD Million)

9.4.6    Market size, by end-use, 2017 - 2030 (USD Million)

9.4.7    China

9.4.7.1   Market size, by product, 2017 - 2030 (USD Million)

9.4.7.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.4.7.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.4.7.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.4.7.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.4.7.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.4.7.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.4.7.2   Market size, by technology, 2017 - 2030 (USD Million)

9.4.7.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.4.7.4   Market size, by application, 2017 - 2030 (USD Million)

9.4.7.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.4.8    India

9.4.8.1   Market size, by product, 2017 - 2030 (USD Million)

9.4.8.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.4.8.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.4.8.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.4.8.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.4.8.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.4.8.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.4.8.2   Market size, by technology, 2017 - 2030 (USD Million)

9.4.8.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.4.8.4   Market size, by application, 2017 - 2030 (USD Million)

9.4.8.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.4.9    Japan

9.4.9.1   Market size, by product, 2017 - 2030 (USD Million)

9.4.9.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.4.9.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.4.9.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.4.9.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.4.9.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.4.9.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.4.9.2   Market size, by technology, 2017 - 2030 (USD Million)

9.4.9.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.4.9.4   Market size, by application, 2017 - 2030 (USD Million)

9.4.9.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.4.10    Australia

9.4.10.1    Market size, by product, 2017 - 2030 (USD Million)

9.4.10.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.4.10.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.4.10.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.4.10.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.4.10.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.4.10.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.4.10.2    Market size, by technology, 2017 - 2030 (USD Million)

9.4.10.3    Market size, by prescription, 2017 - 2030 (USD Million)

9.4.10.4    Market size, by application, 2017 - 2030 (USD Million)

9.4.10.5    Market size, by end-use, 2017 - 2030 (USD Million)

9.5    Latin America

9.5.1    Market size, by country, 2017 - 2030 (USD Million)

9.5.2    Market size, by product, 2017 - 2030 (USD Million)

9.5.2.1   Market size, by glucose monitoring, 2017-2030 (USD Million)

9.5.2.2   Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.5.2.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.5.2.3   Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.5.2.4   Market size, by coagulation testing products, 2017-2030 (USD Million)

9.5.2.5   Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.5.3    Market size, by technology, 2017 - 2030 (USD Million)

9.5.4    Market size, by prescription, 2017 - 2030 (USD Million)

9.5.5    Market size, by application, 2017 - 2030 (USD Million)

9.5.6    Market size, by end-use, 2017 - 2030 (USD Million)

9.5.7    Brazil

9.5.7.1   Market size, by product, 2017 - 2030 (USD Million)

9.5.7.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.5.7.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.5.7.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.5.7.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.5.7.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.5.7.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.5.7.2   Market size, by technology, 2017 - 2030 (USD Million)

9.5.7.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.5.7.4   Market size, by application, 2017 - 2030 (USD Million)

9.5.7.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.5.8    Mexico

9.5.8.1   Market size, by product, 2017 - 2030 (USD Million)

9.5.8.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.5.8.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.5.8.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.5.8.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.5.8.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.5.8.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.5.8.2   Market size, by technology, 2017 - 2030 (USD Million)

9.5.8.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.5.8.4   Market size, by application, 2017 - 2030 (USD Million)

9.5.8.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.6    MEA

9.6.1    Market size, by country, 2017 - 2030 (USD Million)

9.6.2    Market size, by product, 2017 - 2030 (USD Million)

9.6.2.1   Market size, by glucose monitoring, 2017-2030 (USD Million)

9.6.2.2   Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.6.2.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.6.2.3   Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.6.2.4   Market size, by coagulation testing products, 2017-2030 (USD Million)

9.6.2.5   Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.6.3    Market size, by technology, 2017 - 2030 (USD Million)

9.6.4    Market size, by prescription, 2017 - 2030 (USD Million)

9.6.5    Market size, by application, 2017 - 2030 (USD Million)

9.6.6    Market size, by end-use, 2017 - 2030 (USD Million)

9.6.7    South Africa

9.6.7.1   Market size, by product, 2017 - 2030 (USD Million)

9.6.7.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.6.7.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.6.7.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.6.7.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.6.7.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.6.7.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.6.7.2   Market size, by technology, 2017 - 2030 (USD Million)

9.6.7.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.6.7.4   Market size, by application, 2017 - 2030 (USD Million)

9.6.7.5   Market size, by end-use, 2017 - 2030 (USD Million)

9.6.8    Saudi Arabia

9.6.8.1   Market size, by product, 2017 - 2030 (USD Million)

9.6.8.1.1    Market size, by glucose monitoring, 2017-2030 (USD Million)

9.6.8.1.2    Market size, by cardiometabolic testing products, 2017-2030 (USD Million)

9.6.8.1.2.1    Market size, by cardiac marker testing product, 2017-2030 (USD Million)

9.6.8.1.3    Market size, by infectious disease testing products, 2017-2030 (USD Million)

9.6.8.1.4    Market size, by coagulation testing products, 2017-2030 (USD Million)

9.6.8.1.5    Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)

9.6.8.2   Market size, by technology, 2017 - 2030 (USD Million)

9.6.8.3   Market size, by prescription, 2017 - 2030 (USD Million)

9.6.8.4   Market size, by application, 2017 - 2030 (USD Million)

9.6.8.5   Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 10   Company Profiles

10.1    Competitive dashboard

10.2    Abaxis

10.2.1    Business overview

10.2.2    Financial data

10.2.3    Product landscape

10.2.4    Strategic outlook

10.2.5    SWOT analysis

10.3    Abbott

10.3.1    Business overview

10.3.2    Financial data

10.3.3    Product landscape

10.3.4    Strategic outlook

10.3.5    SWOT analysis

10.4    Accubiotech Co, Ltd.

10.4.1    Business overview

10.4.2    Financial data

10.4.3    Product landscape

10.4.4    Strategic outlook

10.4.5    SWOT analysis

10.5    ACON Laboratories, Inc

10.5.1    Business overview

10.5.2    Financial data

10.5.3    Product landscape

10.5.4    Strategic outlook

10.5.5    SWOT analysis

10.6    Becton, Dickinson and Company

10.6.1    Business overview

10.6.2    Financial data

10.6.3    Product landscape

10.6.4    Strategic outlook

10.6.5    SWOT analysis

10.7    bioLytical Laboratories Inc

10.7.1    Business overview

10.7.2    Financial data

10.7.3    Product landscape

10.7.4    Strategic outlook

10.7.5    SWOT analysis

10.8    BioMrieux SA

10.8.1    Business overview

10.8.2    Financial data

10.8.3    Product landscape

10.8.4    Strategic outlook

10.9    Bio-Rad Laboratories, Inc

10.9.1    Business overview

10.9.2    Financial data

10.9.3    Product landscape

10.9.4    Strategic outlook

10.9.5    SWOT analysis

10.10    HemoCue AB (Danaher Corporation)

10.10.1    Business overview

10.10.2    Financial data

10.10.3    Product landscape

10.10.4    Strategic outlook

10.10.5    SWOT analysis

10.11    Dexcom, Inc

10.11.1    Business overview

10.11.2    Financial data

10.11.3    Product landscape

10.11.4    Strategic outlook

10.11.5    SWOT analysis

10.12    Dragerwerk Ag & Co

10.12.1    Business overview

10.12.2    Financial data

10.12.3    Product landscape

10.12.4    Strategic outlook

10.12.5    SWOT analysis

10.13    LifeScan IP Holdings, LLC

10.13.1    Business overview

10.13.2    Financial data

10.13.3    Product landscape

10.13.4    Strategic outlook

10.13.5    SWOT analysis

10.14    Medtronic plc

10.14.1    Business overview

10.14.2    Financial data

10.14.3    Product landscape

10.14.4    Strategic outlook

10.14.5    SWOT analysis

10.15    Meridian Bioscience, Inc

10.15.1    Business overview

10.15.2    Financial data

10.15.3    Product landscape

10.15.4    Strategic outlook

10.15.5    SWOT analysis

10.16    Nova Biomedical

10.16.1    Business overview

10.16.2    Financial data

10.16.3    Product landscape

10.16.4    Strategic outlook

10.16.5    SWOT analysis

10.17    OraSure Technologies, Inc

10.17.1    Business overview

10.17.2    Financial data

10.17.3    Product landscape

10.17.4    Strategic outlook

10.17.5    SWOT analysis

10.18    F. Hoffmann-La Roche

10.18.1    Business overview

10.18.2    Financial data

10.18.3    Product landscape

10.18.4    Strategic outlook

10.18.5    SWOT analysis

10.19    Siemens Healthineers AG

10.19.1    Business overview

10.19.2    Financial data

10.19.3    Product landscape

10.19.4    Strategic outlook

10.19.5    SWOT analysis

10.20    Sysmex Corporation

10.20.1    Business overview

10.20.2    Financial data

10.20.3    Product landscape

10.20.4    Strategic outlook

10.20.5    SWOT analysis

10.21    Trinity Biotech

10.21.1    Business overview

10.21.2    Financial data

10.21.3    Product landscape

10.21.4    Strategic outlook

10.21.5    SWOT analysis
 

Data Tables

TABLE 1    Global point of care testing market, 2017 - 2021 (USD Million)

TABLE 2    Global point of care testing market, 2022 - 2030 (USD Million)

TABLE 3    Global point of care testing market, by product, 2017 - 2021 (USD Million)

TABLE 4    Global point of care testing market, by product, 2022 - 2030 (USD Million)

TABLE 5    Global point of care testing market, by technology, 2017 - 2021 (USD Million)

TABLE 6    Global point of care testing market, by technology, 2022 - 2030 (USD Million)

TABLE 7    Global point of care testing market, by prescription, 2017 - 2021 (USD Million)

TABLE 8    Global point of care testing market, by prescription, 2022 - 2030 (USD Million)

TABLE 9    Global point of care testing market, by application, 2017 - 2021 (USD Million)

TABLE 10    Global point of care testing market, by application, 2022 - 2030 (USD Million)

TABLE 11    Global point of care testing market, by end-use, 2017 - 2021 (USD Million)

TABLE 12    Global point of care testing market, by end-use, 2022 - 2030 (USD Million)

TABLE 13    Global point of care testing market, by region, 2017 - 2021 (USD Million)

TABLE 14    Global point of care testing market, by region, 2022 - 2030 (USD Million)

TABLE 15    Industry impact forces

TABLE 16    POCT test for COVID-19 approved by various regulatory bodies

TABLE 17    Pricing analysis, by cardiac markers, 2021

TABLE 18    Glucose monitoring market size, by region, 2017 - 2021 (USD Million)

TABLE 19    Glucose monitoring market size, by region, 2022 - 2030 (USD Million)

TABLE 20    Strips market, by region, 2017 - 2021 (USD Million)

TABLE 21    Strips market, by region, 2022 - 2030 (USD Million)

TABLE 22    Meters market, by region, 2017 - 2021, (USD Million)

TABLE 23    Meters market, by region, 2017 - 2021, (USD Million)

TABLE 24    Lancets market, by region, 2017 - 2021 (USD Million)

TABLE 25    Lancets market, by region, 2022 - 2030 (USD Million)

TABLE 26    Cardiometabolic testing products market size, by region, 2017 - 2021 (USD Million)

TABLE 27    Cardiometabolic testing products market size, by region, 2022 - 2030 (USD Million)

TABLE 28    Cardiac marker testing products market, by region, 2017 - 2021 (USD Million)

TABLE 29    Cardiac marker testing products market, by region, 2022 - 2030 (USD Million)

TABLE 30    High-sensitivity troponin I (hsTnl) market, by region, 2017 - 2021 (USD Million)

TABLE 31    High-sensitivity troponin I (hsTnl) market, 2022 - 2030 (USD Million)

TABLE 32    Brain natriuretic peptide (BNP) market, by region, 2017 - 2021 (USD Million)

TABLE 33    Brain natriuretic peptide (BNP) market, by region, 2022 - 2030 (USD Million)

TABLE 34    D-dimer market, by region, 2017 - 2021 (USD Million)

TABLE 35    D-dimer market, by region, 2022 - 2030 (USD Million)

TABLE 36    Creatine kinase-MB (CK-MB) market, by region, 2017 - 2021 (USD Million)

TABLE 37    Creatine kinase-MB (CK-MB) market, by region, 2022 - 2030 (USD Million)

TABLE 38    Myoglobin market, by region, 2017 - 2021 (USD Million)

TABLE 39    Myoglobin market, by region, 2022 - 2030 (USD Million)

TABLE 40    Others market, by region, 2017 - 2021 (USD Million)

TABLE 41    Others market, by region, 2022 - 2030 (USD Million)

TABLE 42    Blood Gas/Electrolytes testing products market, by region, 2017 - 2021 (USD Million)

TABLE 43    Blood Gas/Electrolytes testing products market, by region, 2022 - 2030 (USD Million)

TABLE 44    HBA1C testing products market, by region, 2017 - 2021 (USD Million)

TABLE 45    HBA1C testing products market, by region, 2022 - 2030 (USD Million)

TABLE 46    Infectious disease testing products market, by region, 2017 - 2021 (USD Million)

TABLE 47    Infectious disease testing products market, by region, 2022 - 2030 (USD Million)

TABLE 48    Influenza testing products market, by region, 2017 - 2021 (USD Million)

TABLE 49    Influenza testing products market, by region, 2022 - 2030 (USD Million)

TABLE 50    HIV testing products market, by region, 2017 - 2021 (USD Million)

TABLE 51    HIV testing products market, by region, 2022 – 2030 (USD Million)

TABLE 52    Hepatitis C testing products market, by region, 2017 - 2021 (USD Million)

TABLE 53    Hepatitis C testing products market, by region, 2022 - 2030 (USD Million)

TABLE 54    Sexually transmitted disease (STD) testing products market, by region, 2017 - 2021 (USD Million)

TABLE 55    Sexually transmitted disease (STD) testing products market, by region, 2022 - 2030 (USD Million)

TABLE 56    Healthcare-associated Infection (HAI) testing products market, by region, 2017 - 2021 (USD Million)

TABLE 57    Healthcare-associated Infection (HAI) testing products market, by region, 2022 - 2030 (USD Million)

TABLE 58    Respiratory infection testing products market, by region, 2017 - 2021 (USD Million)

TABLE 59    Respiratory infection testing products market, by region, 2022 - 2030 (USD Million)

TABLE 60    Tropical disease testing products market, by region, 2017 - 2021 (USD Million)

TABLE 61    Tropical disease testing products market, by region, 2022 – 2030 (USD Million)

TABLE 62    Other infectious diseases testing products market, by region, 2017 - 2021 (USD Million)

TABLE 63    Other infectious diseases testing products market, by region, 2022 - 2030 (USD Million)

TABLE 64    Coagulation testing products market, by region, 2017 - 2021 (USD Million)

TABLE 65    Coagulation testing products market, by region, 2022 - 2030 (USD Million)

TABLE 66    PT/INR testing products market, by region, 2017 - 2021 (USD Million)

TABLE 67    PT/INR testing products market, by region, 2022 - 2030 (USD Million)

TABLE 68    Activated clotting time (ACT/APTT) testing products market, by region, 2017 - 2021 (USD Million)

TABLE 69    Activated clotting time (ACT/APTT) testing products market, by region, 2022 - 2030 (USD Million)

TABLE 70    Pregnancy and fertility testing products market, by region, 2017 - 2021 (USD Million)

TABLE 71    Pregnancy and fertility testing products market, by region, 2022 – 2030 (USD Million)

TABLE 72    Pregnancy testing products market, by region, 2017 - 2021 (USD Million)

TABLE 73    Pregnancy testing products market, by region, 2022 - 2030 (USD Million)

TABLE 74    Fertility testing products market, by region, 2017 - 2021 (USD Million)

TABLE 75    Fertility testing products market, by region, 2022 - 2030 (USD Million)

TABLE 76    Tumor/Cancer marker testing products market, by region, 2017 - 2021 (USD Million)

TABLE 77    Tumor/Cancer marker testing products market, by region, 2022 - 2030 (USD Million)

TABLE 78    Urinalysis testing products market, by region, 2017 - 2021 (USD Million)

TABLE 79    Urinalysis testing products market, by region, 2022 - 2030 (USD Million)

TABLE 80    Cholesterol testing products market, by region, 2017 - 2021 (USD Million)

TABLE 81    Cholesterol testing products market, by region, 2022 – 2030 (USD Million)

TABLE 82    Hematology testing products market, by region, 2017 - 2021 (USD Million)

TABLE 83    Hematology testing products market, by region, 2022 - 2030 (USD Million)

TABLE 84    Drug-of-Abuse (DoA) testing products market, by region, 2017 - 2021 (USD Million)

TABLE 85    Drug-of-Abuse (DoA) testing products market, by region, 2022 - 2030 (USD Million)

TABLE 86    Fecal occult testing products market, by region, 2017 - 2021 (USD Million)

TABLE 87    Fecal occult testing products market, by region, 2022 - 2030 (USD Million)

TABLE 88    Other products market, by region, 2017 - 2021 (USD Million)

TABLE 89    Other products market, by region, 2022 - 2030 (USD Million)

TABLE 90    Lateral flow assays market, by region, 2017 - 2021 (USD Million)

TABLE 91    Lateral flow assays market, by region, 2022 – 2030 (USD Million)

TABLE 92    Dipsticks market, by region, 2017 - 2021 (USD Million)

TABLE 93    Dipsticks market, by region, 2022 - 2030 (USD Million)

TABLE 94    Microfluidics market, by region, 2017 - 2021 (USD Million)

TABLE 95    Microfluidics market, by region, 2022 - 2030 (USD Million)

TABLE 96    Molecular diagnostics market, by region, 2017 - 2021 (USD Million)

TABLE 97    Molecular diagnostics market, by region, 2022 - 2030 (USD Million)

TABLE 98    Immunoassays market, by region, 2017 - 2021 (USD Million)

TABLE 99    Immunoassays market, by region, 2022 - 2030 (USD Million)

TABLE 100    Agglutination assays market, by region, 2017 - 2021 (USD Million)

TABLE 101    Agglutination assays market, by region, 2022 – 2030 (USD Million)

TABLE 102    Flow-through market, by region, 2017 - 2021 (USD Million)

TABLE 103    Flow-through market, by region, 2022 - 2030 (USD Million)

TABLE 104    Solid phase market, by region, 2017 - 2021 (USD Million)

TABLE 105    Solid phase market, by region, 2022 - 2030 (USD Million)

TABLE 106    Biosensors market, by region, 2017 - 2021 (USD Million)

TABLE 107    Biosensors market, by region, 2022 - 2030 (USD Million)

TABLE 108    OTC testing market, by region, 2017 - 2021 (USD Million)

TABLE 109    OTC testing market, by region, 2022 - 2030 (USD Million)

TABLE 110    Prescription-based testing market, by region, 2017 - 2021 (USD Million)

TABLE 111    Prescription-based testing market, by region, 2022 – 2030 (USD Million)

TABLE 112    Cardio metabolic testing market, by region, 2017 - 2021 (USD Million)

TABLE 113    Cardio metabolic testing market, by region, 2022 - 2030 (USD Million)

TABLE 114    Infectious disease testing market, by region, 2017 - 2021 (USD Million)

TABLE 115    Infectious disease testing market, by region, 2022 - 2030 (USD Million)

TABLE 116    Nephrology testing market, by region, 2017 - 2021 (USD Million)

TABLE 117    Nephrology testing market, by region, 2022 - 2030 (USD Million)

TABLE 118    Drug-of-Abuse (DoA) testing market, by region, 2017 - 2021 (USD Million)

TABLE 119    Drug-of-Abuse (DoA) testing market, by region, 2022 - 2030 (USD Million)

TABLE 120    Blood glucose testing market, by region, 2017 - 2021 (USD Million)

TABLE 121    Blood glucose testing market, by region, 2022 – 2030 (USD Million)

TABLE 122    Pregnancy testing market, by region, 2017 - 2021 (USD Million)

TABLE 123    Pregnancy testing market, by region, 2022 - 2030 (USD Million)

TABLE 124    Cancer biomarker testing market, by region, 2017 - 2021 (USD Million)

TABLE 125    Cancer biomarker testing market, by region, 2022 - 2030 (USD Million)

TABLE 126    Other applications market, by region, 2017 - 2021 (USD Million)

TABLE 127    Other applications market, by region, 2022 - 2030 (USD Million)

TABLE 128    Hospitals market, by region, 2017 - 2021 (USD Million)

TABLE 129    Hospitals market, by region, 2022 - 2030 (USD Million)

TABLE 130    Diagnostic centers market, by region, 2017 - 2021 (USD Million)

TABLE 131    Diagnostic centers market, by region, 2022 – 2030 (USD Million)

TABLE 132    Research laboratories market, by region, 2017 - 2021 (USD Million)

TABLE 133    Research laboratories market, by region, 2022 - 2030 (USD Million)

TABLE 134    Home-care settings market, by region, 2017 - 2021 (USD Million)

TABLE 135    Home-care settings market, by region, 2022 - 2030 (USD Million)

TABLE 136    Others market, by region, 2017 - 2021 (USD Million)

TABLE 137    Others market, by region, 2022 - 2030 (USD Million)

TABLE 138    North America point of care testing market size, by country, 2017 - 2021 (USD Million)

TABLE 139    North America point of care testing market size, by country, 2022 - 2030 (USD Million)

TABLE 140    North America point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 141    North America point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 142    North America point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 143    North America point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 144    North America point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 145    North America point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 146    North America point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 147    North America point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 148    North America point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 149    North America point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 150    North America point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 151    North America point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 152    North America point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 153    North America point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 154    North America point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 155    North America point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 156    North America point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 157    North America point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 158    North America point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 159    North America point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 160    North America point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 161    North America point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 162    U.S. point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 163    U.S. point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 164    U.S. point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 165    U.S. point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 166    U.S. point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 167    U.S. point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 168    U.S. point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 169    U.S. point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 170    U.S. point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 171    U.S. point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 172    U.S. point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 173    U.S. point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 174    U.S. point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 175    U.S. point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 176    U.S. point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 177    U.S. point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 178    U.S. point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 179    U.S. point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 180    U.S. point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 181    U.S. point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 182    U.S. point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 183    U.S. point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 184    Canada point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 185    Canada point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 186    Canada point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 187    Canada point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 188    Canada point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 189    Canada point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 190    Canada point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 191    Canada point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 192    Canada point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 193    Canada point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 194    Canada point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 195    Canada point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 196    Canada point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 197    Canada point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 198    Canada point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 199    Canada point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 200    Canada point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 201    Canada point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 202    Canada point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 203    Canada point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 204    Canada point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 205    Canada point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 206    Europe point of care testing market size, by country, 2017 - 2021 (USD Million)

TABLE 207    Europe point of care testing market size, by country, 2022 - 2030 (USD Million)

TABLE 208    Europe point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 209    Europe point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 210    Europe point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 211    Europe point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 212    Europe point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 213    Europe point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 214    Europe point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 215    Europe point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 216    Europe point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 217    Europe point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 218    Europe point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 219    Europe point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 220    Europe point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 221    Europe point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 222    Europe point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 223    Europe point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 224    Europe point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 225    Europe point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 226    Europe point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 227    Europe point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 228    Europe point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 229    Europe point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 230    Germany point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 231    Germany point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 232    Germany point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 233    Germany point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 234    Germany point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 235    Germany point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 236    Germany point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 237    Germany point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 238    Germany point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 239    Germany point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 240    Germany point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 241    Germany point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 242    Germany point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 243    Germany point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 244    Germany point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 245    Germany point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 246    Germany point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 247    Germany point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 248    Germany point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 249    Germany point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 250    Germany point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 251    Germany point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 252    UK point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 253    UK point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 254    UK point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 255    UK point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 256    UK point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 257    UK point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 258    UK point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 259    UK point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 260    UK point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 261    UK point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 262    UK point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 263    UK point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 264    UK point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 265    UK point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 266    UK point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 267    UK point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 268    UK point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 269    UK point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 270    UK point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 271    UK point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 272    UK point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 273    UK point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 274    France point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 275    France point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 276    France point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 277    France point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 278    France point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 279    France point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 280    France point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 281    France point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 282    France point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 283    France point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 284    France point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 285    France point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 286    France point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 287    France point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 288    France point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 289    France point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 290    France point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 291    France point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 292    France point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 293    France point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 294    France point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 295    France point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 296    Spain point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 297    Spain point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 298    Spain point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 299    Spain point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 300    Spain point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 301    Spain point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 302    Spain point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 303    Spain point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 304    Spain point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 305    Spain point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 306    Spain point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 307    Spain point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 308    Spain point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 309    Spain point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 310    Spain point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 311    Spain point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 312    Spain point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 313    Spain point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 314    Spain point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 315    Spain point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 316    Spain point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 317    Spain point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 318    Italy point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 319    Italy point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 320    Italy point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 321    Italy point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 322    Italy point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 323    Italy point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 324    Italy point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 325    Italy point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 326    Italy point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 327    Italy point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 328    Italy point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 329    Italy point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 330    Italy point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 331    Italy point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 332    Italy point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 333    Italy point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 334    Italy point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 335    Italy point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 336    Italy point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 337    Italy point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 338    Italy point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 339    Italy point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 340    Asia Pacific point of care testing market size, by country, 2017 - 2021 (USD Million)

TABLE 341    Asia Pacific point of care testing market size, by country, 2022 - 2030 (USD Million)

TABLE 342    Asia Pacific point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 343    Asia Pacific point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 344    Asia Pacific point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 345    Asia Pacific point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 346    Asia Pacific point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 347    Asia Pacific point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 348    Asia Pacific point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 349    Asia Pacific point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 350    Asia Pacific point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 351    Asia Pacific point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 352    Asia Pacific point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 353    Asia Pacific point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 354    Asia Pacific point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 355    Asia Pacific point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 356    Asia Pacific point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 357    Asia Pacific point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 358    Asia Pacific point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 359    Asia Pacific point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 360    Asia Pacific point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 361    Asia Pacific point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 362    Asia Pacific point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 363    Asia Pacific point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 364    China point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 365    China point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 366    China point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 367    China point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 368    China point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 369    China point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 370    China point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 371    China point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 372    China point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 373    China point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 374    China point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 375    China point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 376    China point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 377    China point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 378    China point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 379    China point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 380    China point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 381    China point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 382    China point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 383    China point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 384    China point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 385    China point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 386    India point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 387    India point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 388    India point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 389    India point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 390    India point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 391    India point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 392    India point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 393    India point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 394    India point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 395    India point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 396    India point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 397    India point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 398    India point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 399    India point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 400    India point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 401    India point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 402    India point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 403    India point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 404    India point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 405    India point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 406    India point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 407    India point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 408    Japan point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 409    Japan point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 410    Japan point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 411    Japan point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 412    Japan point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 413    Japan point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 414    Japan point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 415    Japan point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 416    Japan point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 417    Japan point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 418    Japan point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 419    Japan point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 420    Japan point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 421    Japan point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 422    Japan point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 423    Japan point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 424    Japan point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 425    Japan point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 426    Japan point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 427    Japan point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 428    Japan point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 429    Japan point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 430    Australia point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 431    Australia point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 432    Australia point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 433    Australia point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 434    Australia point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 435    Australia point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 436    Australia point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 437    Australia point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 438    Australia point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 439    Australia point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 440    Australia point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 441    Australia point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 442    Australia point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 443    Australia point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 444    Australia point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 445    Australia point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 446    Australia point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 447    Australia point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 448    Australia point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 449    Australia point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 450    Australia point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 451    Australia point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 452    Latin America point of care testing market size, by country, 2017 - 2021 (USD Million)

TABLE 453    Latin America point of care testing market size, by country, 2022 - 2030 (USD Million)

TABLE 454    Latin America point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 455    Latin America point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 456    Latin America point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 457    Latin America point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 458    Latin America point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 459    Latin America point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 460    Latin America point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 461    Latin America point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 462    Latin America point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 463    Latin America point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 464    Latin America point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 465    Latin America point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 466    Latin America point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 467    Latin America point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 468    Latin America point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 469    Latin America point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 470    Latin America point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 471    Latin America point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 472    Latin America point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 473    Latin America point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 474    Latin America point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 475    Latin America point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 476    Brazil point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 477    Brazil point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 478    Brazil point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 479    Brazil point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 480    Brazil point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 481    Brazil point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 482    Brazil point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 483    Brazil point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 484    Brazil point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 485    Brazil point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 486    Brazil point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 487    Brazil point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 488    Brazil point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 489    Brazil point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 490    Brazil point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 491    Brazil point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 492    Brazil point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 493    Brazil point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 494    Brazil point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 495    Brazil point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 496    Brazil point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 497    Brazil point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 498    Mexico point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 499    Mexico point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 500    Mexico point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 501    Mexico point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 502    Mexico point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 503    Mexico point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 504    Mexico point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 505    Mexico point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 506    Mexico point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 507    Mexico point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 508    Mexico point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 509    Mexico point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 510    Mexico point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 511    Mexico point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 512    Mexico point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 513    Mexico point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 514    Mexico point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 515    Mexico point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 516    Mexico point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 517    Mexico point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 518    Mexico point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 519    Mexico point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 520    Middle East and Africa point of care testing market size, by country, 2017 - 2021 (USD Million)

TABLE 521    Middle East and Africa point of care testing market size, by country, 2022 - 2030 (USD Million)

TABLE 522    Middle East and Africa point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 523    Middle East and Africa point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 524    Middle East and Africa point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 525    Middle East and Africa point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 526    Middle East and Africa point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 527    Middle East and Africa point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 528    Middle East and Africa point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 529    Middle East and Africa point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 530    Middle East and Africa point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 531    Middle East and Africa point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 532    Middle East and Africa point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 533    Middle East and Africa point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 534    Middle East and Africa point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 535    Middle East and Africa point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 536    Middle East and Africa point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 537    Middle East and Africa point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 538    Middle East and Africa point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 539    Middle East and Africa point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 540    Middle East and Africa point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 541    Middle East and Africa point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 542    Middle East and Africa point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 543    Middle East and Africa point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 544    South Africa point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 545    South Africa point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 546    South Africa point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 547    South Africa point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 548    South Africa point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 549    South Africa point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 550    South Africa point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 551    South Africa point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 552    South Africa point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 553    South Africa point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 554    South Africa point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 555    South Africa point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 556    South Africa point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 557    South Africa point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 558    South Africa point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 559    South Africa point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 560    South Africa point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 561    South Africa point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 562    South Africa point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 563    South Africa point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 564    South Africa point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 565    South Africa point of care testing market size, by end-use, 2022 - 2030 (USD Million)

TABLE 566    Saudi Arabia point of care testing market size, by product, 2017 - 2021 (USD Million)

TABLE 567    Saudi Arabia point of care testing market size, by product, 2022 - 2030 (USD Million)

TABLE 568    Saudi Arabia point of care testing market, by glucose monitoring, 2017-2021 (USD Million)

TABLE 569    Saudi Arabia point of care testing market, by glucose monitoring, 2022-2030 (USD Million)

TABLE 570    Saudi Arabia point of care testing market, by cardiometabolic testing products, 2017-2021 (USD Million)

TABLE 571    Saudi Arabia point of care testing market, by cardiometabolic testing products, 2022-2030 (USD Million)

TABLE 572    Saudi Arabia point of care testing market, by cardiac marker testing product, 2017-2021 (USD Million)

TABLE 573    Saudi Arabia point of care testing market, by cardiac marker testing product, 2022-2030 (USD Million)

TABLE 574    Saudi Arabia point of care testing market, by infectious disease testing products, 2017-2021 (USD Million)

TABLE 575    Saudi Arabia point of care testing market, by infectious disease testing products, 2022-2030 (USD Million)

TABLE 576    Saudi Arabia point of care testing market, by coagulation testing products, 2017-2021 (USD Million)

TABLE 577    Saudi Arabia point of care testing market, by coagulation testing products, 2022-2030 (USD Million)

TABLE 578    Saudi Arabia point of care testing market, by pregnancy and fertility testing products, 2017-2021 (USD Million)

TABLE 579    Saudi Arabia point of care testing market, by pregnancy and fertility testing products, 2022-2030 (USD Million)

TABLE 580    Saudi Arabia point of care testing market size, by technology, 2017 - 2021 (USD Million)

TABLE 581    Saudi Arabia point of care testing market size, by technology, 2022 - 2030 (USD Million)

TABLE 582    Saudi Arabia point of care testing market size, by prescription, 2017 - 2021 (USD Million)

TABLE 583    Saudi Arabia point of care testing market size, by prescription, 2022 - 2030 (USD Million)

TABLE 584    Saudi Arabia point of care testing market size, by application, 2017 - 2021 (USD Million)

TABLE 585    Saudi Arabia point of care testing market size, by application, 2022 - 2030 (USD Million)

TABLE 586    Saudi Arabia point of care testing market size, by end-use, 2017 - 2021 (USD Million)

TABLE 587    Saudi Arabia point of care testing market size, by end-use, 2022 - 2030 (USD Million)
 

Charts & Figures

FIG. 1    Top-down approach

FIG. 2    Breakdown of primary participants

FIG. 3    Point of care testing industry 360⁰ synopsis, 2017 - 2030

FIG. 4    Industry segmentation

FIG. 5    Industry landscape, 2017 - 2030 (USD Million)

FIG. 6    Growth potential analysis, by product

FIG. 7    Growth potential analysis, by technology

FIG. 8    Growth potential analysis, by prescription

FIG. 9    Growth potential analysis, by application

FIG. 10    Growth potential analysis, by end-use

FIG. 11    Global market share analysis, 2021

FIG. 12    Company share analysis, 2021 – North America

FIG. 13    Company share analysis, 2021 – Europe

FIG. 14    Company share analysis, 2021 – Asia Pacific

FIG. 15    Company share analysis, 2021 – Latin America

FIG. 16    Company share analysis, 2021 – MEA

FIG. 17    Porter’s analysis

FIG. 18    Company matrix analysis, 2021

FIG. 19    PESTEL analysis

FIG. 20    Key segment trends, by product

FIG. 21    Key segment trends, by technology

FIG. 22    Key segment trends, by prescription

FIG. 23    Key segment trends, by application

FIG. 24    Key segment trends, by end-use

FIG. 25    Key regional trends

FIG. 26    Strategy dashboard, 2021